Data Health USA is a Ashland, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Healthcare Management Partners, LLC is a hospital and healthcare services management firm. HMP is a firm led by a team of C-Level healthcare executives that quickly define and solve problems to produce exceptional results for healthcare organizations and their stakeholders. With its extensive experience, Financial Modeling and Data Analysis Tools and action-based business model, HMP provides senior executive led management, financial advisory and litigation support services to hospitals and other healthcare organizations and their creditors, investors and business partners. The complex and ever-changing nature of the healthcare markets can test even the strongest organizations. Healthcare Management Partners serves as advisor to hospitals and other healthcare providers facing strategic decisions directly impacting current or future financial performance. HMP also frequently serves banks, bond holders, private equity firms or committees of unsecured creditors and their legal and accounting advisors in conjunction with complex business transactions or restructurings involving healthcare providers. We provide creditor advisory and operational and financial due diligence. Unlike many of our competitors, every financial advisory services engagement is led on the ground by experienced C-Level healthcare executives.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Premise Health is here to change the way people see and experience healthcare. We help organizations take healthcare farther – by bringing it closer than ever. We’ve created a worksite health model that achieves better patient engagement, and delivers higher-value programs that sustainably improve health outcomes to worksite and distributed workforces. For employers, this means finally controlling costs – while delivering a leading-edge health benefit that actually benefits health. On behalf of 220+ clients, Premise Health operates over 500 onsite health centers, pharmacies, and fitness centers in 46 states and 2 U.S. territories.
Sonus USA Inc. is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.